Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ciprofloxacin with or without initial betadine-impregnated mesh for bacterial acute otitis externa
IRCT20190913044761N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Apr 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ciprofloxacin and povidone-iodine in external otitis (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Response to treatment of bacterial acute otitis externa. Started Apr 2019; status: completed.
02
Drugs
ciprofloxacinpovidone-iodine
03
Conditions
external otitis
Beyond the preview
Go deeper on IRCT20190913044761N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190913044761N1.